{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:02:02Z","timestamp":1769763722128,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00702-024-02822-x","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T16:02:15Z","timestamp":1724083335000},"page":"1455-1462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinicians\u2019 viewpoints on current paradigms of care and research in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6799-0753","authenticated-orcid":false,"given":"Thomas","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Buhmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Delf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Klostermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kupsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Lipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"M\u00fcngersdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram","family":"von Pannwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"S\u00fcdmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"2822_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1468-1331.2012.03798.x","volume":"20","author":"D Berg","year":"2013","unstructured":"Berg D, Godau J, Seppi K, Behnke S, Liepelt-Scarfone I, Lerche S, Stockner H, Gaenslen A, Mahlknecht P, Huber H, Srulijes K, Klenk J, Fassbender K, Maetzler W, Poewe W (2013) The PRIPS study: screening battery for subjects at risk for Parkinson\u2019s disease. Eur J Neurol 20:102\u2013108","journal-title":"Eur J Neurol"},{"key":"2822_CR2","first-page":"787","volume":"73","author":"W Birkmayer","year":"1961","unstructured":"Birkmayer W, Hornykiewicz O (1961) The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia. Wien Klin Wochenschr 73:787\u2013788","journal-title":"Wien Klin Wochenschr"},{"key":"2822_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF01217333","volume":"210","author":"W Birkmayer","year":"1967","unstructured":"Birkmayer W, Mentasti M (1967) Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes). Arch Psychiatr Nervenkr 210:29\u201335","journal-title":"Arch Psychiatr Nervenkr"},{"key":"2822_CR4","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/microorganisms9081716","volume":"9","author":"D Cadar","year":"2021","unstructured":"Cadar D, Jellinger KA, Riederer P, Strobel S, Monoranu CM, Tappe D (2021) No Metagenomic evidence of causative viral pathogens in postencephalitic parkinsonism following encephalitis lethargica. Microorganisms 9:1716","journal-title":"Microorganisms"},{"key":"2822_CR5","first-page":"259","volume":"9","author":"F Cardoso","year":"2023","unstructured":"Cardoso F, Goetz CG, Mestre TA, Sampaio C, Adler CH, Berg D, Bloem BR, Burn DJ, Fitts MS, Gasser T, Klein C, de Tijssen MAJ, Lang AE, Lim SY, Litvan I, Meissner WG, M\u00f6llenhauer B, Okubadejo N, Okun MS, Postuma RB, Svenningsson P, Tan LCS, Tsunemi T, Wahlstr\u00f6m-Helgren S, Gershanik OS, Fung VSC, Trenkwalder C (2023) A Statement of the MDS on biological definition, staging, and classification of Parkinson\u2019s disease. Mov Disord 9:259\u2013266","journal-title":"Mov Disord"},{"key":"2822_CR6","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s12031-020-01497-9","volume":"70","author":"SN Gad","year":"2020","unstructured":"Gad SN, Nofal S, Raafat EM, Ahmed AAE (2020) Lixisenatide reduced damage in hippocampus CA1 neurons in a rat model of cerebral ischemia-reperfusion possibly via the ERK\/P38 signaling pathway. J Mol Neurosci 70:1026\u20131037","journal-title":"J Mol Neurosci"},{"key":"2822_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33\u201339","journal-title":"Arch Neurol"},{"key":"2822_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3233\/JAD-2009-0996","volume":"16","author":"E Gr\u00fcnblatt","year":"2009","unstructured":"Gr\u00fcnblatt E, Bartl J, Zehetmayer S, Ringel TM, Bauer P, Riederer P, Jacob CP (2009) Gene expression as peripheral biomarkers for sporadic Alzheimer\u2019s disease. J Alzheimers Dis 16:627\u2013634","journal-title":"J Alzheimers Dis"},{"key":"2822_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/01.WNF.0000229546.81245.7F","volume":"29","author":"RA Hauser","year":"2006","unstructured":"Hauser RA, Russ H, Haeger DA, Bruguiere-Fontenille M, M\u00fcller T, Wenning GK (2006) Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease. Clin Neuropharmacol 29:322\u2013330","journal-title":"Clin Neuropharmacol"},{"key":"2822_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, Postuma R, Stoessl AJ, Lang AE (2024) A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 23:191\u2013204","journal-title":"Lancet Neurol"},{"key":"2822_CR11","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.parkreldis.2015.10.006","volume":"21","author":"K Horvath","year":"2015","unstructured":"Horvath K, Aschermann Z, Acs P, Deli G, Janszky J, Komoly S, Balazs E, Takacs K, Karadi K, Kovacs N (2015) Minimal clinically important difference on the motor examination part of MDS-UPDRS. Parkinsonism Relat Disord 21:1421\u20131426","journal-title":"Parkinsonism Relat Disord"},{"key":"2822_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s10143-024-02475-0","volume":"47","author":"H Irfan","year":"2024","unstructured":"Irfan H, Muneer SU, Maheshwari AB, Kumar N, Iftikhar S (2024) Lixisenatide in early Parkinson\u2019s disease: efficacy, safety, and future directions: a correspondence. Neurosurg Rev 47:232","journal-title":"Neurosurg Rev"},{"key":"2822_CR13","first-page":"100161","volume":"7","author":"SH Isaacson","year":"2022","unstructured":"Isaacson SH, Pagan FL, Lew MF, Pahwa R (2022) Should \u201con-demand\u201d treatments for Parkinson\u2019s disease OFF episodes be used earlier? Clin Park Relat Disord 7:100161","journal-title":"Clin Park Relat Disord"},{"key":"2822_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/archneur.1987.00520210023013","volume":"44","author":"WC Koller","year":"1987","unstructured":"Koller WC, Herbster G (1987) Adjuvant therapy of parkinsonian tremor. Arch Neurol 44:921\u2013923","journal-title":"Arch Neurol"},{"key":"2822_CR15","doi-asserted-by":"publisher","first-page":"1036068","DOI":"10.3389\/fneur.2022.1036068","volume":"13","author":"PA LeWitt","year":"2022","unstructured":"LeWitt PA, Stocchi F, Arkadir D, Caraco Y, Adar L, Perlstein I, Case R, Giladi N (2022) The pharmacokinetics of continuous subcutaneous levodopa\/carbidopa infusion: findings from the ND0612 clinical development program. Front Neurol 13:1036068","journal-title":"Front Neurol"},{"key":"2822_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40263-014-0220-0","volume":"29","author":"N Malek","year":"2015","unstructured":"Malek N, Grosset DG (2015) Medication adherence in patients with Parkinson\u2019s disease. CNS Drugs 29:47\u201353","journal-title":"CNS Drugs"},{"key":"2822_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3233\/JPD-230055","volume":"13","author":"AE Martinez-Nunez","year":"2023","unstructured":"Martinez-Nunez AE, LeWitt PA (2023) Drugs to the rescue: comparison of on-demand therapies for off symptoms in Parkinson\u2019s disease. J Parkinsons Dis 13:441\u2013451","journal-title":"J Parkinsons Dis"},{"key":"2822_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0304-3940(01)01758-X","volume":"303","author":"W Meissner","year":"2001","unstructured":"Meissner W, Reum T, Paul G, Harnack D, Sohr R, Morgenstern R, Kupsch A (2001) Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. Neurosci Lett 303:165\u2013168","journal-title":"Neurosci Lett"},{"key":"2822_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1750-1326-7-26","volume":"7","author":"L Molochnikov","year":"2012","unstructured":"Molochnikov L, Rabey JM, Dobronevsky E, Bonucelli U, Ceravolo R, Frosini D, Grunblatt E, Riederer P, Jacob C, Haron-Peretz J, Bashenko Y, Youdim MB, Mandel SA (2012) A molecular signature in blood identifies early Parkinson\u2019s disease. Mol Neurodegener 7:26","journal-title":"Mol Neurodegener"},{"key":"2822_CR20","first-page":"307","volume":"15","author":"T M\u00fcller","year":"2021","unstructured":"M\u00fcller T (2021) View point: disease modification and cell secretome based approaches in Parkinson\u2019s disease: are we on the right track? Biologics 15:307\u2013316","journal-title":"Biologics"},{"key":"2822_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/14656566.2022.2045275","volume":"23","author":"T M\u00fcller","year":"2022","unstructured":"M\u00fcller T (2022) What are the main considerations when prescribing pharmacotherapy for Parkinson\u2019s disease? Expert Opin Pharmacother 23:745\u2013750","journal-title":"Expert Opin Pharmacother"},{"key":"2822_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S1474-4422(24)00097-8","volume":"23","author":"T M\u00fcller","year":"2024","unstructured":"M\u00fcller T, M\u00f6hr JD (2024) Negative findings from trials with NLY01 or deferiprone for Parkinson\u2019s disease. Lancet Neurol 23:558\u2013559","journal-title":"Lancet Neurol"},{"key":"2822_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/cells10040873","volume":"10","author":"T M\u00fcller","year":"2021","unstructured":"M\u00fcller T, Mueller BK, Riederer P (2021) Perspective: treatment for disease modification in chronic neurodegeneration. Cells 10:873","journal-title":"Cells"},{"key":"2822_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41531-023-00535-8","volume":"9","author":"AC Muller-Nedebock","year":"2023","unstructured":"Muller-Nedebock AC, Dekker MCJ, Farrer MJ, Hattori N, Lim SY, Mellick GD, Rektorova I, Salama M, Schuh AFS, Stoessl AJ, Sue CM, Tan AH, Vidal RL, Klein C, Bardien S (2023) Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson\u2019s disease. NPJ Parkinsons Dis 9:110","journal-title":"NPJ Parkinsons Dis"},{"key":"2822_CR25","doi-asserted-by":"publisher","first-page":"106041","DOI":"10.1016\/j.parkreldis.2024.106041","volume":"122","author":"E Mulroy","year":"2024","unstructured":"Mulroy E, Erro R, Bhatia KP, Hallett M (2024) Refining the clinical diagnosis of Parkinson\u2019s disease. Parkinsonism Relat Disord 122:106041","journal-title":"Parkinsonism Relat Disord"},{"key":"2822_CR26","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0378","author":"K Natrajan","year":"2024","unstructured":"Natrajan K, Kaushal M, George B, Kanapuru B, Theoret MR (2024) FDA approval summary: ciltacabtagene autoleucel for relapsed or refractory multiple myeloma. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-0378","journal-title":"Clin Cancer Res"},{"key":"2822_CR27","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3389\/fneur.2019.00896","volume":"10","author":"FAP Nijhuis","year":"2019","unstructured":"Nijhuis FAP, van den Heuvel L, Bloem BR, Post B, Meinders MJ (2019) The patient\u2019s perspective on shared decision-making in advanced Parkinson\u2019s disease: a cross-sectional survey study. Front Neurol 10:896","journal-title":"Front Neurol"},{"key":"2822_CR28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.1468-1331.2011.03614.x","volume":"19","author":"D Nyholm","year":"2012","unstructured":"Nyholm D, Johansson A, Lennernas H, Askmark H (2012) Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial. Eur J Neurol 19:820\u2013826","journal-title":"Eur J Neurol"},{"key":"2822_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3233\/JPD-202285","volume":"11","author":"CW Olanow","year":"2021","unstructured":"Olanow CW, Espay AJ, Stocchi F, Ellenbogen AL, Leinonen M, Adar L, Case RJ, Orenbach SF, Yardeni T, Oren S, Poewe W (2021) Continuous subcutaneous levodopa delivery for Parkinson\u2019s disease: a randomized study. J Parkinsons Dis 11:177\u2013186","journal-title":"J Parkinsons Dis"},{"key":"2822_CR30","doi-asserted-by":"publisher","first-page":"e0161559","DOI":"10.1371\/journal.pone.0161559","volume":"11","author":"C Ossig","year":"2016","unstructured":"Ossig C, Gandor F, Fauser M, Bosredon C, Churilov L, Reichmann H, Horne MK, Ebersbach G, Storch A (2016) Correlation of quantitative motor state assessment using a kinetograph and patient diaries in advanced PD: data from an observational study. PLoS ONE 11:e0161559","journal-title":"PLoS ONE"},{"key":"2822_CR31","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1002\/mds.28758","volume":"36","author":"W Poewe","year":"2021","unstructured":"Poewe W, Stocchi F, Arkadir D, Ebersbach G, Ellenbogen AL, Giladi N, Isaacson SH, Kieburtz K, LeWitt P, Olanow CW, Simuni T, Thomas A, Zlotogorski A, Adar L, Case R, Oren S, Fuchs OS, Rosenfeld O, Sasson N, Yardeni T, Espay AJ (2021) Subcutaneous levodopa infusion for Parkinson\u2019s disease: 1-year data from the open-label BeyoND study. Mov Disord 36:2687\u20132692","journal-title":"Mov Disord"},{"key":"2822_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.14089","author":"RB Postuma","year":"2024","unstructured":"Postuma RB, Weintraub D, Simuni T, Rodriguez-Violante M, Leentjens AFG, Hu MT, Espay AJ, Erro R, Dujardin K, Bohnen NI, Berg D, Mestre TA, Marras C (2024) Anticipating tomorrow: tailoring Parkinson\u2019s symptomatic therapy using predictors of outcome. Mov Disord Clin Pract. https:\/\/doi.org\/10.1002\/mdc3.14089","journal-title":"Mov Disord Clin Pract"},{"key":"2822_CR33","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00702-019-02025-9","volume":"126","author":"P Riederer","year":"2019","unstructured":"Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Kruger R, Muller T, Reichmann H, Riess O, Storch A, Strobel S, van E T, Volker HU, Winkler J, Winklhofer KF, Wullner U, Zunke F, Monoranu CM (2019) alpha-Synuclein in Parkinson\u2019s disease: causal or bystander? J Neural Transm 126:815\u2013840","journal-title":"J Neural Transm"},{"key":"2822_CR34","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1205158","volume":"368","author":"WM Schuepbach","year":"2013","unstructured":"Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Halbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel CC, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltete D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Kruger R, Pinsker MO, Amtage F, Regis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G (2013) Neurostimulation for Parkinson\u2019s disease with early motor complications. N Engl J Med 368:610\u2013622","journal-title":"N Engl J Med"},{"key":"2822_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mds.26855","volume":"32","author":"M Senek","year":"2017","unstructured":"Senek M, Nielsen EI, Nyholm D (2017) Levodopa-entacapone-carbidopa intestinal gel in Parkinson\u2019s disease: a randomized crossover study. Mov Disord 32:283\u2013286","journal-title":"Mov Disord"},{"key":"2822_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K (2024) A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23:178\u2013190","journal-title":"Lancet Neurol"},{"key":"2822_CR37","first-page":"9358153","volume":"2017","author":"G Suarez-Cedeno","year":"2017","unstructured":"Suarez-Cedeno G, Suescun J, Schiess MC (2017) Earlier intervention with deep brain stimulation for Parkinson\u2019s disease. Parkinsons Dis 2017:9358153","journal-title":"Parkinsons Dis"},{"key":"2822_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.baga.2016.02.001","volume":"6","author":"D Sulzer","year":"2016","unstructured":"Sulzer D, Cragg SJ, Rice ME (2016) Striatal dopamine neurotransmission: regulation of release and uptake. Basal Ganglia 6:123\u2013148","journal-title":"Basal Ganglia"},{"key":"2822_CR39","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/mds.27027","volume":"32","author":"N Titova","year":"2017","unstructured":"Titova N, Chaudhuri KR (2017) Personalized medicine in Parkinson\u2019s disease: time to be precise. Mov Disord 32:1147\u20131154","journal-title":"Mov Disord"},{"key":"2822_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/mdc3.12266","volume":"3","author":"TK Yaw","year":"2016","unstructured":"Yaw TK, Fox SH, Lang AE (2016) Clozapine in Parkinsonian rest tremor: a review of outcomes, adverse reactions, and possible mechanisms of action. Mov Disord Clin Pract 3:116\u2013124","journal-title":"Mov Disord Clin Pract"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-024-02822-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T16:03:20Z","timestamp":1732982600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-024-02822-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2822"],"URL":"https:\/\/doi.org\/10.1007\/s00702-024-02822-x","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}